Nanoscale markers of esophageal field carcinogenesis: Potential implications for esophageal cancer screening

Endoscopy

Volumn 45, Issue 12, 2013, Pages 983-988

  Konda, Vani J A ^a   Cherkezyan, Lusik ^b   Subramanian, Hariharan ^b   Wroblewski, Kirsten ^c   Damania, Dhwanil ^b   Becker, Valentin ^d   Gonzalez, Mariano Haba Ruiz ^a   Koons, Ann ^a   Goldberg, Michael ^e   Ferguson, Mark K ^a   Waxman, Irving ^a   Roy, Hermant K ^e   Backman, Vadim ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b Northwestern University   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HEMATOXYLIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BARRETT ESOPHAGUS; CANCER SCREENING; CARCINOGENESIS; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DYSPLASTIC BARRETT ESOPHAGUS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL WAVE SPECTROSCOPY MICROSCOPY; PRIORITY JOURNAL; SQUAMOUS CELL; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; CYTODIAGNOSIS; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; MALE; MICROSCOPY; MIDDLE AGED; NANOTECHNOLOGY; OPTICS AND PHOTONICS; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 84889564096     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0033-1344617     Document Type: Article

References (24)

1. Konda V. J., Dalal K. Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions. Ther Clin Risk Manag: 2011; 7 447 458
2. Gerson L. B., Shetler K., Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology: 2002; 123 461 467 (Pubitemid 34827190)
3. Sharma P., Sidorenko E. I. Are screening and surveillance for Barrett's oesophagus really worthwhile? Gut: 2005; 54 Suppl 1 i27 32 (Pubitemid 40293006)
4. Hvid-Jensen F., Pedersen L., Drewes A. M. et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med: 2011; 365 1375 1383
5. Wani S., Falk G., Hall M. et al. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol: 2011; 9 220 227
6. Hirst N. G., Gordon L. G., Whiteman D. C. et al. Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective?. Review of economic evaluations. J Gastroenterol Hepatol: 2011; 26 247 254
7. Wallace M. B., Perelman L. T., Backman V. et al. Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy. Gastroenterology: 2000; 119 677 682
8. Georgakoudi I., Jacobson B. C., Van Dam J. et al. Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology: 2001; 120 1620 1629 (Pubitemid 32523481)
9. Qiu L., Pleskow D. K., Chuttani R. et al. Multispectral scanning during endoscopy guides biopsy of dysplasia in Barrett's esophagus. Nat Med: 2010; 16 603 606
10. Pyhtila J. W., Chalut K. J., Boyer J. D. et al. In situ detection of nuclear atypia in Barrett's esophagus by using angle-resolved low-coherence interferometry. Gastrointest Endosc: 2007; 65 487 491 (Pubitemid 46275650)
11. Brabender J., Marjoram P., Lord R. V. et al. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma. Cancer Epidemiol Biomarkers Prev: 2005; 14 2113 2117 (Pubitemid 41603254)
12. Yakoub D., Keun H. C., Goldin R. et al. Metabolic profiling detects field effects in nondysplastic tissue from esophageal cancer patients. Cancer Res: 2010; 70 9129 9136
13. Slaughter D. P., Southwick H. W., Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer: 1953; 6 963 968
14. Roy H. K., Backman V., Goldberg M. J. Colon cancer screening: the good, the bad, and the ugly. Arch Intern Med: 2006; 166 2177 2179 (Pubitemid 44748763)
15. Kopelovich L., Henson D. E., Gazdar A. F. et al. Surrogate anatomic/functional sites for evaluating cancer risk: an extension of the field effect. Clin Cancer Res: 1999; 5 3899 3905 (Pubitemid 30013763)
16. Subramanian H., Roy H. K., Pradhan P. et al. Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. Cancer Res: 2009; 69 5357 5363
17. Damania D., Subramanian H., Tiwari A. K. et al. Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture. Biophys J: 2010; 99 989 996
18. Kim J. S., Pradhan P., Backman V. et al. The influence of chromosome density variations on the increase in nuclear disorder strength in carcinogenesis. Phys Biol: 2011; 8 015004
19. Barer R., Tkaczyk S. Refractive index of concentrated protein solutions. Nature: 1954; 173 821 822
20. Davies H. G., Wilkins M. HF, Chayen J. et al. The use of the interference microscope to determine dry mass in living cells and as a quantitative cytochemical method. Q J Microsc Sci: 1954; 95 271 304
21. Wang J. S., Canto M. I. Predicting neoplastic progression in Barrett's esophagus. Ann Gastroentol Hepatol: 2010; 1 1 10
22. Pepe M. S., Etzioni R., Feng Z. et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst: 2001; 93 1054 1061 (Pubitemid 32717537)
23. Sridhar S., Schembri F., Zeskind J. et al. Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genomics: 2008; 9 259
24. Kemp R., Turic B. Can early lung cancer be detected from buccal mucosal scrapings? Chest: 2005; 128 154S